Back to mobile site

Iovanace Biotherapeutics (IOVA) PT Raised to $16 at TD Cowen Following Raised Outlook

September 29, 2026 10:00 AM EDT Send to a Friend
TD Cowen analyst Nicholas Lorusso raised the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $16.00 (from $10.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login